Advertisement

China Pharma Holdings, Inc. CPHI

Set alert

Price alert · CPHI

All alert types
0.62 USD -0.03 -3.86%

At close · Oct 30

0.61 -0.01 -1.87%

After hours · Oct 30, 7:58 PM ET

Bid
0.60 × 4,400
Ask
0.64 × 1,000
0.6065 Day range 0.6748
0.52 52-week range 8.10
YTD
-48.36%
1 year
-63.88%
Open
0.65
Prev close
0.65
Mkt cap
26.88M
Vol
184.28K
Avg vol
1.90M
EPS
-0.42
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6065
High
0.6748
Forward P/E
0.00
Beta
0.71
Short ratio
0.22
Inst. own
0.21%
Dividend
0.00
Ex-div date
50-d avg
0.214
200-d avg
0.2588
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 13, 2024Earnings: -0.06; estimate 0; surprise —%
  • Apr 15, 2025Split: 1 for 10
Signals (93)
NameDateAgo
MACD: Sell SignalOct 22, 20261 week ago
SMA: BearishOct 9, 20263 weeks ago
SMA: BearishOct 9, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
MACD: Buy SignalSep 23, 20261 month ago
SMA: BearishAug 21, 20262 months ago
SMA: BearishAug 17, 20262 months ago
MACD: Sell SignalJul 28, 20263 months ago
SMA: BullishJul 21, 20263 months ago
RSI: OverboughtJul 21, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BullishJul 15, 20263 months ago
MACD: Buy SignalJul 15, 20263 months ago
RSI: OverboughtJul 15, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BullishJul 2, 20264 months ago
SMA: BearishJun 23, 20264 months ago
MACD: Sell SignalJun 5, 20264 months ago
MACD: Buy SignalJun 3, 20265 months ago
MACD: Sell SignalMay 26, 20265 months ago
SMA: BullishMay 12, 20265 months ago
MACD: Buy SignalMay 12, 20265 months ago
RSI: OverboughtMay 12, 20265 months ago
SMA: BearishApr 27, 20266 months ago
MACD: Sell SignalApr 27, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 23, 20266 months ago
SMA: BullishApr 15, 20266 months ago
SMA: BearishApr 14, 20266 months ago
MACD: Buy SignalFeb 23, 20268 months ago
MACD: Sell SignalFeb 2, 20269 months ago
RSI: OversoldFeb 2, 20269 months ago
MACD: Buy SignalJan 7, 20269 months ago
MACD: Sell SignalDec 11, 202510 months ago
SMA: BearishDec 10, 202510 months ago
SMA: BullishDec 8, 202510 months ago
SMA: BearishDec 4, 202511 months ago
SMA: BullishDec 2, 202511 months ago
MACD: Buy SignalNov 20, 202511 months ago
SMA: BearishOct 30, 20251 year ago
SMA: BullishOct 29, 20251 year ago
SMA: BearishOct 27, 20251 year ago
SMA: BullishOct 24, 20251 year ago
SMA: BearishOct 22, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BullishOct 7, 20251 year ago
SMA: BearishOct 3, 20251 year ago
MACD: Sell SignalSep 30, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BearishSep 26, 20251 year ago
RSI: OverboughtSep 24, 20251 year ago
SMA: BullishSep 17, 20251 year ago
RSI: OverboughtSep 17, 20251 year ago
RSI: OverboughtSep 11, 20251 year ago
SMA: BullishSep 5, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
RSI: OversoldAug 11, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
SMA: BullishJul 24, 20251 year ago
SMA: BearishJul 15, 20251 year ago
SMA: BullishJul 11, 20251 year ago
SMA: BearishJun 18, 20251 year ago
MACD: Buy SignalJun 17, 20251 year ago
SMA: BullishJun 16, 20251 year ago
SMA: BearishMay 28, 20251 year ago
MACD: Sell SignalMay 28, 20251 year ago
SMA: BullishMay 9, 20251 year ago
SMA: BearishMay 1, 20251 year ago
SMA: BullishApr 30, 20251 year ago
MACD: Buy SignalApr 24, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
SMA: BearishApr 4, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
MACD: Buy SignalMar 27, 20251 year ago
MACD: Sell SignalMar 24, 20251 year ago
MACD: Buy SignalMar 7, 20251 year ago
SMA: BullishMar 6, 20251 year ago
MACD: Sell SignalMar 3, 20251 year ago
SMA: BearishFeb 28, 20251 year ago
MACD: Buy SignalFeb 19, 20251 year ago
SMA: BullishFeb 12, 20251 year ago
SMA: BearishFeb 10, 20251 year ago
MACD: Sell SignalFeb 5, 20251 year ago
MACD: Buy SignalJan 29, 20251 year ago
SMA: BullishJan 28, 20251 year ago
SMA: BearishJan 23, 20251 year ago
SMA: BullishJan 15, 20251 year ago
MACD: Sell SignalJan 14, 20251 year ago
RSI: OverboughtJan 6, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago
RSI: OversoldDec 13, 20241 year ago

Key statistics

Market cap
3.47M
Enterprise value
6.68M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.55
Price / book
0.26
EPS (TTM)
-0.25
Beta
0.71
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-70.48%
Revenue (TTM)
6.25M
Revenue growth
-15.80%
Free cash flow
669.60K
Total cash
739.34K
Total debt
4.06M
Return on equity
-74.89%
Shares outstanding
19.25M
Short % of float
1.22%
50-day average
0.214
200-day average
0.2588

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
CPHI Revenue — quarterly 948.34K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CPHI Net income — quarterly -1.46M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CPHI EPS — quarterly -0.04
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CPHI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 20240.00-0.06——
Aug 14, 2024Jun 1, 20240.00-0.09——
May 15, 2024Mar 1, 20240.00-0.07——
Nov 13, 2023Sep 1, 20230.00-0.30——
Aug 14, 2023Jun 1, 20230.00-0.30——
May 12, 2023Mar 1, 20230.00-0.30——

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
China

News

Your note

Sign in to keep a note on CPHI — it syncs with the Stock Master app.

Insider holders

CPHI insider holders
InsiderRelationLatest transactionDateShares held
LI ZHILINChief Executive OfficerStock Award(Grant)Sep 28, 202315,138,100

Institution ownership

CPHI institution ownership
Holder% heldSharesValueReported
Xtx Topco Ltd0.11%21,5873.88KSep 29, 2024
Two Sigma Securities, LLC0.10%19,0473.43KSep 29, 2024
First Community Trust Na0.00%305Sep 29, 2024

Fund ownership

CPHI fund ownership
Holder% heldSharesValueReported
Bridgeway Funds Inc-Ultra Small Company Market Fund0.04%14,5002.61KJun 29, 2023
Advertisement